University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital
Search Site | Find a Doctor
Print this page
FONT SIZE
Home > Doctors > Michael J. Aminoff

Michael J. Aminoff, M.D.

Director of the Parkinson's Disease and Movement Disorders Clinic

Dr. Michael J. Aminoff is an internationally recognized neurologist and expert in diagnosing and treating Parkinson's disease at UCSF Medical Center. His work focuses on particular aspects of Parkinson's disease, including movement and cognitive issues, such as disturbances to memory, perception and judgment. Aminoff is executive vice chair of Neurology and director of the Parkinson's Disease and Movement Disorders Clinic. He also is involved in treating and studying epilepsy and other movement disorders.

Aminoff graduated with honors from University College in London in 1962 and from the University College Hospital Medical School in 1965 in the United Kingdom. He completed post-doctoral training in London teaching hospitals. He joined UCSF Medical Center in 1974. In 2000, Aminoff was awarded a doctorate in science from the University of London. He is board certified in three specialties — electrodiagnostic medicine, clinical neurophysiology and neurology. Aminoff is the editor and chief of Muscle and Nerve, a major medical journal; serves on several medical and scientific editorial boards; and has authored nearly 200 research publications and numerous books.

Conditions & Treatments

Clinics

Epilepsy Center
400 Parnassus Ave., Eighth Floor
San Francisco, CA 94143
Phone: (415) 353-2437
Fax: (415) 353-2837

Hours: Monday to Friday
8 a.m. – 5 p.m.

Parkinson's Disease and Movement Disorders Clinic
400 Parnassus Ave., Eighth Floor
San Francisco, CA 94143
Phone: (415) 353-2273
Fax: (415) 353-2898

Hours: Monday to Friday
8 a.m. – 5 p.m.

More about Michael J. Aminoff

Education

University of London 1965

Residencies

University College Hospital Medical School, United Kingdom, Neurology 1972

Selected Research and Publications

  1. Mittermeyer G, Christine CW, Rosenbluth KH, Baker SL, Starr P, Larson P, Kaplan PL, Forsayeth J, Aminoff MJ, Bankiewicz KS. Long-Term Evaluation of a Phase 1 Study of AADC Gene Therapy for Parkinson's Disease. Hum Gene Ther. 2012 Apr; 23(4):377-81.
  2. Aminoff MJ, Boller F, Swaab DF. Parkinson's disease. Handb Clin Neurol. 2012; 103:ix.
  3. Aminoff MJ, Boller F, Swaab DF. Foreword. Handb Clin Neurol. 2012; 104:vii.
  4. Aminoff MJ, Boller F, Swaab DF. Foreword. Handb Clin Neurol. 2012; 105:vii.
  5. Gottwald MD, Aminoff MJ. Therapies for dopaminergic-induced dyskinesias in Parkinson disease. Ann Neurol. 2011 Jun; 69(6):919-27.
  6. Charles JA. Trends in American Board of Psychiatry and Neurology specialties and neurologic subspecialties. Neurology. 2011 May 10; 76(19):1680; author reply 1680-1.
  7. Chou KL, Zamudio J, Schmidt P, Price CC, Parashos SA, Bloem BR, Lyons KE, Christine CW, Pahwa R, Bodis-Wollner I, Oertel WH, Suchowersky O, Aminoff MJ, Malaty IA, Friedman JH, Okun MS. Hospitalization in Parkinson disease: a survey of National Parkinson Foundation Centers. Parkinsonism Relat Disord. 2011 Jul; 17(6):440-5.
  8. Aminoff MJ, Boller F, Swaab DF. Hyperkinetic movement disorders. Foreword. Handb Clin Neurol. 2011; 100:vii.
  9. Aminoff MJ, Boller F, Swaab DF. Muscular dystrophies. Foreword. Handb Clin Neurol. 2011; 101:vii.
  10. Aminoff MJ, Boller F, Swaab DF. We spend about one-third of our life either sleeping or attempting to do so. Handb Clin Neurol. 2011; 98:vii.
  11. Aminoff MJ, Christine CW, Friedman JH, Chou KL, Lyons KE, Pahwa R, Bloem BR, Parashos SA, Price CC, Malaty IA, Iansek R, Bodis-Wollner I, Suchowersky O, Oertel WH, Zamudio J, Oberdorf J, Schmidt P, Okun MS. Management of the hospitalized patient with Parkinson's disease: current state of the field and need for guidelines. Parkinsonism Relat Disord. 2011 Mar; 17(3):139-45.
  12. Forsayeth J, Bankiewicz KS, Aminoff MJ. Gene therapy for Parkinson's disease: where are we now and where are we going? Expert Rev Neurother. 2010 Dec; 10(12):1839-45.
  13. Valles F, Fiandaca MS, Eberling JL, Starr PA, Larson PS, Christine CW, Forsayeth J, Richardson RM, Su X, Aminoff MJ, Bankiewicz KS. Qualitative imaging of adeno-associated virus serotype 2-human aromatic L-amino acid decarboxylase gene therapy in a phase I study for the treatment of Parkinson disease. Neurosurgery. 2010 Nov; 67(5):1377-85.
  14. Faulkner LR, Juul D, Pascuzzi RM, Aminoff MJ, Crumrine PK, Dekosky ST, Jozefowicz RF, Massey JM, Pirzada N, Tilton A. Trends in American Board of Psychiatry and Neurology specialties and neurologic subspecialties. Neurology. 2010 Sep 21; 75(12):1110-7.
  15. Aminoff MJ, Swaab DF. History of neurology. Foreword. Handb Clin Neurol. 2010; 95:vii-viii.
  16. Aminoff MJ, Boller F, Swaab DF. Bacterial infections of the central nervous system. Foreword. Handb Clin Neurol. 2010; 96:vii.
  17. Aminoff MJ, Boller F, Swaab DF. Foreword. Handb Clin Neurol. 2010; 97:vii.
  18. Tien I, Glaser SD, Aminoff MJ. Characterization of gait abnormalities in Parkinson's disease using a wireless inertial sensor system. Conf Proc IEEE Eng Med Biol Soc. 2010; 2010:3353-6.
  19. Christine CW, Starr PA, Larson PS, Eberling JL, Jagust WJ, Hawkins RA, VanBrocklin HF, Wright JF, Bankiewicz KS, Aminoff MJ. Safety and tolerability of putaminal AADC gene therapy for Parkinson disease. Neurology. 2009 Nov 17; 73(20):1662-9.
  20. Douglas VC, DeArmond SJ, Aminoff MJ, Miller BL, Rabinovici GD. Seizures in corticobasal degeneration: a case report. Neurocase. 2009 Aug; 15(4):352-6.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions by logging on to UCSF Profiles.

Home • Terms of Use • Site Map • Contact Us       © 2002 - 2012 The Regents of The University of California